Goodwin provides a full-service offering to emerging companies and venture capital companies, supporting clients from initial seed financing stages through to exit transactions. The life sciences practice is co-chaired by Mitch Bloom and Kingsley Taft from Boston, and the technology and emerging companies team is jointly led by Kenneth Gordon in Boston and Craig Schmitz in New York. Bill Schnoor, based in Boston, specializes in business and securities law, private equity work, and acquisitions. Danielle Lauzon, who focuses on life sciences and healthcare information technology services clients, and William Collins, who is experienced in formations, capital markets transactions and exit strategies, bolster the Boston team. In Silicon Valley, Caine Moss assists companies in the software, AI, internet, and financial services sectors.
Legal 500 Editorial commentary
Key clients
- Rippling
- Coalition
- Open AI
- Tome Biosciences
- Upstream Bio
- Jobber
- Battery Ventures
- Myeloid Therapeutics
- ReNAgade Therapeutics
- ElevateBio
- Versanis Bio
- Truework
- Convergent Therapeutics
- A16z
Work highlights
- Advised ElevateBio on its $401m Series D financing, led by AyurMaya Capital Management Fund, managed by Matrix Capital Management.
- Represented Rippling in its $500m convertible note financing round.
- Represented Andreessen Horowitz in the $16m Series A financing of Prepared.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Leading lawyers
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
The lawyer(s) leading their teams.
Mitch Bloom, Kingsley Taft, Kenneth Gordon, Craig Schmitz